COMPASS Pathways plc

Approval AI-extracted

COMP360

treatment-resistant depression (TRD)

Date

TBD

Approval decision · Date TBD estimated

What's at stake A final FDA approval decision on COMP360 for treatment-resistant depression (TRD) is expected Date TBD.

Primary source · SEC 8-K verified 14h ago

“COMP360 represents a fundamentally different approach for patients with treatment resistant depression, unlike any other treatment approved today.”